Financials data is unavailable for this security.
View more
Year on year NeuPath Health Inc grew revenues 5.50% from 62.65m to 66.10m while net income improved from a loss of 4.14m to a smaller loss of 107.00k.
Gross margin | 19.04% |
---|---|
Net profit margin | 0.01% |
Operating margin | -0.04% |
Return on assets | 0.01% |
---|---|
Return on equity | -0.34% |
Return on investment | 0.02% |
More ▼
Cash flow in CADView more
In 2023, NeuPath Health Inc increased its cash reserves by 109.43%, or 1.66m. The company earned 3.03m from its operations for a Cash Flow Margin of 4.58%. In addition the company generated 1.59m cash from investing, though they paid out 2.96m more in financing than they received.
Cash flow per share | 0.0444 |
---|---|
Price/Cash flow per share | 4.05 |
Book value per share | 0.3908 |
---|---|
Tangible book value per share | 0.0098 |
More ▼
Balance sheet in CADView more
Current ratio | 1.03 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.5303 |
---|---|
Total debt/total capital | 0.3477 |
More ▼